If you made any changes in Pure these will be visible here soon.

Personal profile

Biography

Overview

Bonny is a Senior Research Fellow at MUCHE. Prior to joining MUCHE she was a Research Fellow at the Centre for Health Economics, Research and Evaluation at the University of Technology Sydney (UTS) for six years. She has also worked at AstraZeneca in the United Kingdom as a senior health economist, Access Economics in Canberra as a senior economist, and the Social Policy Evaluation and Research Centre at the Australian National University as an Assistant researcher.

Experience

Bonny’s expertise is in pharmaceutical policy in Australia, conducting and reviewing economic evaluations of healthcare interventions and technologies, and analysing linked administrative data to inform economic evaluations. Dr Parkinson leads a team of researchers conducting evaluations of submissions to the Pharmaceutical Benefits Advisory Committee (PBAC) and researching economic evaluation methodology. She was a member of the Ezetimibe Review Reference Group for the Australian Government Department of Health (2016-2017). Her PhD was on “Pharmaceutical Policy in Australia: Developing Methods to Manage Uncertainty in Health Technology Assessment”, for which she received the UTS Chancellor’s List award in 2016.

During her time at UTS she conducted numerous evaluations of submissions to the PBAC, the Medical Services Advisory Committee (MSAC) and the National Diabetes Subsidy Scheme (NDSS). For this work she was awarded the UTS Research Excellence Through Partnership award in 2013. In recognition of her expertise in reviewing economic evaluations, she was an invited member of the international Delphi panel which developed the AdViSHE tool – a tool that can be used to assess the validation status of health economic decision models.

Bonny has excellent skills in presenting complex economic research in ways that captivates an audience’s attention and is understandable. She teaches health economics as of the Masters of Public Health and regularly teaches short courses on economic evaluation.  In 2014 she was invited by the Australian Chapter of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR) to present at the workshop ‘Risky Business: Decision Making in Healthcare with Economic Uncertainty’, and in 2018 she was invited to present and participate in a panel at the workshop on ‘PBAC submissions’.

Bonny was also an executive member of the Australian Health Economics Society (AHES) committee (2012-2016). In 2015-2016 she was acting secretary and was involved with organising the 2015 AHES conference. She is currently co-organising the 2017 AHES conference in Sydney. In 2013 and 2014, Bonny co-conceived and co-organised the first and second Australian Health Economics Doctoral workshop. The feedback from participants was very positive in the first two years that the workshop is now a permanent fixture of the annual Australian Health Economics Society conference.

Education/Academic qualification

Health Economics, Doctor of philosophy

20112014

Health Economics, Master of Science, University of York

20062007

Economics, Econometrics, Bachelor of Economics (Honours), Australian National University

19992002

Fingerprint Dive into the research topics where Bonny Parkinson is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 13 Similar Profiles
Cost-Benefit Analysis Medicine & Life Sciences
Costs and Cost Analysis Medicine & Life Sciences
Quality-Adjusted Life Years Medicine & Life Sciences
Breast Neoplasms Medicine & Life Sciences
Health Medicine & Life Sciences
Mandatory Programs Medicine & Life Sciences
Tryptamines Medicine & Life Sciences
Decision Support Techniques Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2015 2022

Australian hitech manufacturer takes-on prostate cancer

Parkinson, B., Gillatt, D., Krenus, D. & Hicks, R. J.

1/10/1730/09/20

Project: Research

Hide and seek with hereditary cancer: Improving detection of colorectal cancer patients with a high risk of Lynch syndrome

Parkinson, B., Taylor, N., Tucker, K., Macrae, F., Gill, A. J., Canfell, K., Pachter, N., Solomon, M., Shaw, T., Kench, J. G., Mitchell, G., Williams, R., Lakhani, S., Marfan, H., Debono, D., Long, J., Morris, S., Phan-Thien, K., Wright, C. M. & Potter, M.

30/06/1729/06/20

Project: Research

Research Outputs 2004 2019

Comparing theory and non-theory based implementation approaches to improving referral practices in cancer genetics: a cluster randomised trial protocol

Morrow, A., Hogden, E., Kang, Y-J., Steinberg, J., Canfell, K., Solomon, M., Kench, J. G., Gill, A. J., Shaw, T., Pachter, N., Parkinson, B., Wolfenden, L., Mitchell, G., Macrae, F. A., Tucker, K. & Taylor, N., 20 Jun 2019, In : Trials. 20, 1, 12 p., 373.

Research output: Contribution to journalArticleResearchpeer-review

Open Access
File
Hereditary Nonpolyposis Colorectal Neoplasms
Clinical Protocols
Referral and Consultation
Neoplasms
Colorectal Neoplasms

Cost-effectiveness of reclassifying triptans in Australia: Application of an economic evaluation approach to regulatory decisions

Parkinson, B., Gumbie, M., Cutler, H., Gauld, N., Mumford, V. & Haywood, P., Mar 2019, In : Value in Health. 22, 3, p. 293-302 10 p.

Research output: Contribution to journalArticleResearchpeer-review

Tryptamines
Cost-Benefit Analysis
Migraine Disorders
Pharmacists
Headache Disorders

Economic evaluations of childhood hearing loss screening programmes: A systematic review and critique

Sharma, R., Gu, Y., Ching, T. Y. C., Marnane, V. & Parkinson, B., Jun 2019, In : Applied Health Economics and Health Policy. 17, 3, p. 331-357 27 p.

Research output: Contribution to journalArticleResearchpeer-review

Hearing Loss
Cost-Benefit Analysis
Hearing
Quality-Adjusted Life Years
Language Development Disorders
Oral Contraceptives
Pharmacists
Cost-Benefit Analysis
Prescriptions
Costs and Cost Analysis

Mapping the Strengths and Difficulties Questionnaire onto the Child Health Utility 9D in a large study of children

Sharma, R., Gu, Y., Sinha, K., Aghdaee, M. & Parkinson, B., Sep 2019, In : Quality of Life Research. 28, 9, p. 2429-2441 13 p.

Research output: Contribution to journalArticleResearchpeer-review

Statistical Factor Analysis
Adolescent Health Services
Mental Health Services
Nonparametric Statistics
Cost-Benefit Analysis

Activities 2008 2018

Introducing Quality Adjusted Life Years (QALYs)

Bonny Parkinson (Speaker)
25 Sep 201826 Sep 2018

Activity: Talk or presentationOral presentation

Career pathways after a PhD

Bonny Parkinson (Speaker)
24 Sep 2018

Activity: Talk or presentationInvited talk

Section 3: Economic evaluation

Bonny Parkinson (Speaker)
3 Dec 2018

Activity: Talk or presentationInvited talk

An economic evaluation framework to inform the scheduling of medicines in Australia

Bonny Parkinson (Speaker)
30 May 20181 Jun 2018

Activity: Talk or presentationOral presentation

Career pathways after a PhD? Where to next

Bonny Parkinson (Speaker)
20 Sep 2017

Activity: Talk or presentationInvited talk

Press / Media

Impacts

Australian technology detecting hearing loss in children

Mutsa Gumbie (Participant), Henry Cutler (Participant), Bonny Parkinson (Participant), Rachel Song (Participant), Ross Bowman (Participant), Harvey Dillon (Participant), Carolyn Mee (Participant)

Impact: Public policy impacts, Quality of life impacts, Social impacts

Enhancing medicine scheduling decisions through economics

Bonny Parkinson (Participant), Henry Cutler (Participant), Mutsa Gumbie (Participant), Natalie Gauld (Participant), Virginia Mumford (Participant), Philip Haywood (Participant)

Impact: Public policy impacts, Economic impacts, Quality of life impacts

Improving health and spending money wisely: evaluating medicines and vaccines for the Australian Government

Henry Cutler (Participant), Bonny Parkinson (Participant), Martin Hoyle (Participant), Mutsa Gumbie (Participant), Rachel Song (Participant), Andrew Partington (Participant), Varinder Jeet (Participant), Elizabeth Seil (Participant), Alicia Norman (Participant), Virginia Mumford (Participant), Sanjyot Vagholkar (Participant), Lisa Pont (Participant), Janaki Amin (Participant)

Impact: Quality of life impacts, Economic impacts, Public policy impacts